Oragenics Files 8-K Report
Ticker: OGEN · Form: 8-K · Filed: Jul 10, 2024 · CIK: 1174940
Sentiment: neutral
Topics: sec-filing, 8-k, financial-update
Related Tickers: OGEN
TL;DR
Oragenics filed an 8-K today, likely with financial updates. Keep an eye out.
AI Summary
On July 10, 2024, Oragenics, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and significant occurrences. No specific financial figures or new events were detailed in the provided excerpt.
Why It Matters
This filing signals that Oragenics, Inc. is providing updated information to the SEC, which could include material events or financial disclosures relevant to investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report, which typically contains routine disclosures rather than immediate, high-impact news.
Key Players & Entities
- Oragenics, Inc. (company) — Registrant
- July 10, 2024 (date) — Date of Report
FAQ
What specific events are being reported under 'Other Events'?
The provided excerpt does not detail the specific 'Other Events' being reported.
Are there any new financial statements or exhibits attached to this filing?
The filing indicates 'Financial Statements and Exhibits' are included, but the content of these is not specified in the excerpt.
What is the primary purpose of this 8-K filing for Oragenics, Inc.?
The filing is a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, indicating it reports significant events or financial information.
What is Oragenics, Inc.'s principal executive office address?
Oragenics, Inc.'s principal executive offices are located at 1990 Main Street, Suite 750, Sarasota, FL 34236.
When is Oragenics, Inc.'s fiscal year end?
Oragenics, Inc.'s fiscal year ends on December 31.
Filing Stats: 432 words · 2 min read · ~1 pages · Grade level 11.1 · Accepted 2024-07-10 08:00:30
Filing Documents
- form8-k.htm (8-K) — 42KB
- ex99-1.htm (EX-99.1) — 17KB
- 0001493152-24-026724.txt ( ) — 232KB
- ogen-20240710.xsd (EX-101.SCH) — 3KB
- ogen-20240710_lab.xml (EX-101.LAB) — 33KB
- ogen-20240710_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on this July 10 th , 2024. ORAGENICS, INC. (Registrant) BY: /s/ Janet Huffman Janet Huffman Chief Financial Officer